1. Introduction {#s0005}
===============

Polymers derived from natural sources have been reported to possess versatile applications in biomedical and pharmaceuticals. Their availability in abundance, renewability, safety and biocompatible nature has encouraged the formulation scientist to substitute them for synthetic additives. Further, the presence of large number of reactive functional groups on the polymeric backbone of polysaccharides endows them with inherent bioadhesive potential. Natural polysaccharidic bioadhesive films as dosage forms are receiving considerable attention in the pharmaceutical industry as novel, patient compliant and convenient products due to their small size and thickness ([@b0085], [@b0115], [@b0120], [@b0180]). Moreover, ease of manufacturing, cost effective method of preparation and biocompatible nature of these films have promoted their applicability for both local and systemic delivery of therapeutic agents.

Tamarind Seed Polysaccharide (TSP) is derived from seed kernels of Tamarind (*Tamarindus indica* L.), belonging to family Leguminosae, a plant indigenous to India, Bangladesh, Myanmar, Sri Lanka, Malaysia, and Thailand ([@b0055]). The TSP structure comprises of β (1→4)-[d]{.smallcaps}-glucan backbone, substituted at position 6 of the glucopyranosyl units mainly by single α-[d]{.smallcaps}-xylopyranosyl residues as well as by disaccharide side chains composed of β-[d]{.smallcaps}-galactopyranosyl-(1→2)-α-[d]{.smallcaps}-xylopyranosyl residues ([@b0170]). TSP is a high molecular weight polysaccharide (720--880 kDa), containing glucose, xylose and galactose units, in a molecular ratio of ∼3:2:1 ([@b0075]). TSP has been reported to possess mucoadhesive ([@b0195]) and control release properties ([@b0225]). It has been employed in the textile printing as a thickener ([@b0010]) and in food industry as a thickening, stabilizing and gelling agent ([@b0145]).

*Candida vaginitis* is one of the most commonly occurring infection affecting the majority of women during their lifetime. The vast incidence of this infection has stimulated the need for the development of therapeutic strategies that ensure successful eradication of the infection while maintaining the safety and therapeutic efficacy of the formulation and avoid problems like first pass effect associated with systemic delivery. In this scenario, local treatment of *C*. *vaginitis* represents a rational choice for its management.

Nystatin is a broad spectrum polyene antibiotic, produced by *Streptomyces noursei* strains ([@b0110]). It exerts its antifungal action by binding to sterols, chiefly ergosterol of the fungal cell membrane, and the formation of barrel-like membrane-spanning channels ([@b0030]). Nystatin has both an antifungal and fungistatic activities ([@b0190]) and has been found to possess broader spectrum of activity as compared to azole antifungals ([@b0035]). Commercially, very few vaginal nystatin formulations are available (Mycostatin®, Nilstat®, Nadostine®). These are cream formulations that suffer from the drawbacks of being leaky and messy in nature and also require a frequent dosing regimen owing to the self-cleansing action of the vagina, namely the secretion of mucus and humid site of administration ([@b0235]). In order to overcome these problems researchers started working up on designing of bioadhesive vaginal formulations, which would provide an intimate contact of the formulation at target site, improve residence time and thereby provide appropriate drug release characteristics. Nystatin gels ([@b0095]) and microparticulate ([@b0125]) bioadhesive formulations have been designed for vaginal delivery of nystatin, however the release of nystatin from these formulations is either too little (30% nystatin release from polyacrylic acid cysteamine conjugate gels in 7 days) ([@b0095]) or a burst release has been observed ([@b0125]), indicating a need towards the development of a mucoadhesive formulation that would provide controlled drug release and vaginal residence characteristics.

Response Surface Methodology (RSM) is widely used as a tool for designing of experiments in the development and optimization of drug delivery systems ([@b0005], [@b0215], [@b0220]) including preformulation studies to facilitate screening of excipients and to study the effects of different formulations and/or process variables on the drug release or dissolution characteristics ([@b0020], [@b0100], [@b0130]).

In the present study, Tamarind seed polysaccharide (TSP) bioadhesive films were prepared employing 3^2^ randomized full factorial design and optimized in terms of different properties using RSM approach. The simultaneous evaluation of the effects of formulation variables (polymer and plasticizer concentration) on mechanical, swelling and bioadhesive properties of the film was carried out to determine the optimum formulation composition using RSM approach. TSP films were tested as drug carrier systems for vaginal delivery of nystatin. In vitro drug release studies and residence time studies were carried out to ensure appropriate drug release characteristics and vaginal retention. The antifungal activity of vaginal films was also determined by observing the zone of inhibition produced in vitro.

2. Material and method {#s0010}
======================

2.1. Materials {#s0015}
--------------

Tamarind seed polysaccharide (TSP) was received as a gift sample from Encore Natural Polymer Pvt. Ltd (Naroda, Ahmadabad, India). Propylene glycol (PG) was procured from SD Fine chemicals ltd, India. Nystatin was received as a gift sample from DSM Sinochem Pharmaceuticals, India. *Candida albicans* ATCC 10231 was purchased from Institute of Microbial Technology (IMTECH), Chandigarh, India. All reagents and chemicals were of analytical grade and used as received.

Simulated vaginal fluid (SVF) was prepared according to the previous literature report with the following composition (g L^−1^): NaCl, 3.51; KOH, 1.40; Ca(OH)~2~, 0.222; bovine serum albumin, 0.018; lactic acid, 2.00; acetic acid, 1.00; glycerol, 0.160; urea, 0.400 and glucose, 5.00. The mixed solution was adjusted to a pH of 4.2 ([@b0155]).

2.2. Preparation of TSP films {#s0020}
-----------------------------

TSP films were prepared by the solvent casting method ([@b0200]). Briefly TSP (1--2% w/v) was dissolved in distilled water on a magnetic stirrer (Remi equipments, Mumbai India), this was followed by the addition of plasticizer (PG; 15--20%v/v). The resulting viscous solution (50 mL) was poured into polypropylene petri plates (553.86 cm^2^). The petri plates were stored at 4 °C for 24 h to remove all the entrapped air bubbles ([@b0140]) and then dried in an oven (Narang Scientific Works Pvt. Ltd., New Delhi) at 50 °C for 72 h. The dried films were carefully removed and checked for any imperfections or air bubbles and stored in desiccator till use.

2.3. Experimental design for optimization {#s0025}
-----------------------------------------

A 3^2^ randomized full factorial design with replicated centre point, consisting of 13 runs ([Table 1](#t0005){ref-type="table"}), was used for optimization of films. Response surface methodology (RSM) was used to investigate the effect of independent variables (TSP concentration; *X*~1~ and PG (plasticizer) concentration; *X*~2~) on a range of dependent variables. The independent variables were evaluated at three levels. The higher and lower levels of each factor were coded as +1 and −1, respectively, and the mean value as 0 ([Table 1](#t0005){ref-type="table"}). Contact angle (Y1), spreading coefficient (Y2), bioadhesive strength (maximum detachment force) (Y3), tensile strength (Y4), % elongation at break (%EB) (Y5), swelling index (SI) (Y6) and water vapour transmission rate (WVTR) (Y7) were used as dependent (response) variables ([Table 1](#t0005){ref-type="table"}). Design Expert® trial version 8.0.7.1(Stat-ease Inc., Minneapolis, MN, USA) was used for performing experimental design, polynomial fitting and ANOVA results. Appropriate models were selected by comparing lacks of fit *p* values and *R*^2^ values. Graphs were plotted for statistically significant models with insignificant lacks of fit at desired confidence levels. The formulations were optimized using desirability approach to select optimum combination of formulation variables (*X*~1~ and *X*~2~) that provide desired bioadhesive and physical, mechanical and interfacial properties of TSP films.

2.4. Mass uniformity, thickness and folding endurance {#s0030}
-----------------------------------------------------

Mass uniformity of the patches was tested using an electronic digital balance (Precisa Gravimetric AG). Thickness of the films was measured at three different randomly selected positions using a digital vernier calliper and a mean value was calculated. For testing folding endurance the films were folded manually at the same place, films which got folded for ⩾300 times without breaking were said to pass this test ([@b0165]).

2.5. Swelling index (SI) measurement {#s0035}
------------------------------------

The hydration characteristics of polymer play an important role in bioadhesion. Agar plates (2% w/v agar in simulated vaginal fluid (SVF)) were prepared and maintained at 37 °C. The initial diameter of individual films was determined. These were then allowed to swell on the surface of the agar plates. The samples were removed at regular intervals and the increase in the diameter of the films was determined for a period of 8 h. SI was calculated from the following formula:$$\% S\mspace{6mu}(\mathit{SI}) = (D_{t} - D_{o})/D_{o} \ast 100$$where %*S* is the % swelling, *D~t~* and *D~o~* the diameter of the swollen and original film respectively after time ([@b0140]).

2.6. Determination of interfacial properties: contact angle and spreading coefficient measurement {#s0040}
-------------------------------------------------------------------------------------------------

Contact angle of SVF with surface of films was obtained by modification of a method reported by [@b0080]. A drop of SVF (200 μL) was placed gently on the top of the film surface with a micropipette from a distance of 1 cm. Images were captured using a digital camera. The angle between the tangent line of the drop and the film surface was calculated using Image J software. Spreading coefficient at the SVF and film surface was calculated using the equation:$$S = \gamma_{L}(\cos\ \theta - 1)$$where *γ~L~* is the surface tension of SVF calculated using stalagmometer method ([@b0105]).

2.7. Determination of mechanical properties: tensile strength & % elongation at break (%EB) measurement {#s0045}
-------------------------------------------------------------------------------------------------------

The mechanical properties of films were evaluated using texture analyser equipment equipped with a 10 Kg load cell (TA.XT plus, Stable Micro Systems, UK) ([@b0185]). A film strip of area 10 cm^2^ was held between two clamps of texture analyser probe positioned 3 cm apart. The film strip was pulled by the upper arm (trigger load 0.05 N) at the rate of 5.0 mm/s to a distance of 100 mm before returning to the starting point. The force required to break the film and the elongation at break were measured. The calculations were performed using Texture-Pro CT V1.3 Build 14 software ([@b0090]).

2.8. Determination of bioadhesive strength/maximum detachment force {#s0050}
-------------------------------------------------------------------

The in vitro bioadhesive strength was evaluated using a texture analyser equipment (TA.XT plus, Stable Micro Systems, UK) equipped with a 100 g load cell. Fresh porcine vaginal mucosa was used as a model membrane. The mucosal membrane was obtained from slaughter house was thoroughly cleaned by removing the underlying connective tissue and washed with SVF. It was mounted securely in place on a membrane tissue holder and wetted with 0.1 mL of SVF. The mucosa was exposed to the probe through a circular disc having a cavity of diameter 1.27 cm. A sample of the prepared TSP film (1 cm^2^) was attached (using double sided adhesive tape) to the base of the cylindrical probe, which was fixed to the mobile arm of the texture analyser. The cylindrical probe with the film attached to its base was lowered onto the circular disc at a speed of 0.5 mm/s and a force of 1 N for a contact time of 30 s. It was then withdrawn at a rate of 0.5 mm/s to a distance of 10 mm. The mucoadhesive performance of the samples was determined by measuring the resistance to the withdrawal of the probe (maximum detachment force) reflecting the bioadhesive characteristics of the TSP film ([@b0060]).

2.9. Determination of water vapour transmission rate (WVTR) {#s0055}
-----------------------------------------------------------

The WVTR (g m^−2^ h^−1^) of TSP films was determined using a vapometer (Delfin Technologies Ltd., Kuopio, Finland). Films were mounted and sealed on the top of open specially designed beakers filled with 8.9 mL of distilled water. The system was then equilibrated for 2 h at room temperature (25 ± 2 °C, 42--46% RH) and thereafter WVTR was measured ([@b0210]).

2.10. Preparation of drug loaded films {#s0060}
--------------------------------------

The optimized TSP blank films were loaded with nystatin a 'polyene antibiotic'. It is commercially available as a mixture of three different constituents (*A*~1~, *A*~2~, *A*~3~). Nystatin sample containing \>90% of constituent *A*~1~ with a potency of 6830 units/mg as specified and supplied by the manufacturer was used in the present study.

For the preparation of drug loaded TSP films nystatin (10,000 units) was dispersed either alone (film code T14D) or in a ratio of 1:0.5 (film code T14DT~0.5~) and 1:1 with Tween 60 (film code T14DT) in water. Tween 60 was used as a solubilizing agent for nystatin ([@b0230]). The nystatin dispersion was poured into TSP solution containing PG. The solutions were mixed and poured into petri-plates, which were stored at 4 °C for 24 h and subsequently dried in an oven (Narang Scientific Works Pvt. Ltd., New Delhi) at 50 °C for 72 h.

2.11. Physiochemical interaction studies {#s0065}
----------------------------------------

### 2.11.1. Differential scanning calorimetry {#s0070}

The physicochemical interaction among drug and other excipients incorporated in the film was characterized by carrying out the DSC (Mettler Toledo 812E, Switzerland) studies. TSP films were heated at a heating rate of 10 °C min^−1^ in the heating range of 30--400 °C under nitrogen atmosphere.

### 2.11.2. Scanning electron microscope characterization of films {#s0075}

The morphological characteristics of blank, drug loaded and drug and Tween loaded TSP films were examined using a JEOL JSM-6610 LV scanning electron microscope (SEM) (JEOL Ltd., Tokyo, Japan) operated at 15 kV. The films were coated with a layer of gold under argon atmosphere for 70 s prior to imaging at different magnifications.

2.12. Drug content uniformity {#s0080}
-----------------------------

The uniformity of drug distribution in films was determined 1 cm^2^ patches of T14DT films from five different locations. The patch was weighed, homogenized (Remi equipments, Mumbai, India) and dissolved in SVF with continuous stirring on a magnetic stirrer to extract the drug. The drug content was determined using the standard plot of nystatin.

2.13. In vitro drug release and residence time {#s0085}
----------------------------------------------

In vitro drug release studies were carried out using simulated dynamic vaginal system ([@b0245]). This system is based upon the rate of secretion and maximum volume of mucus in the vagina. Freshly isolated porcine vaginal tissue, obtained from slaughter house, was cleaned, and cut into size of 5 × 5 cm^2^. The vaginal mucosa was mounted on a glass slide inclined at an angle of 30° with the mucosal side facing upwards. The optimized drug loaded TSP film (size 1 cm^2^) was mounted on the mucosal membrane. SVF was allowed to flow on the film at a rate of 5 mL h^−1^ with the help of a peristaltic pump (Electrolab, PP201V, Mumbai, India). A flask was placed under the glass slide and the perfused SVF was collected, at predetermined time intervals. The absorbance of the samples was measured at 306 nm using UV--Vis spectrophotometer and the drug release was determined by extrapolation from the calibration curve. Residence time of the films on the vaginal mucosa was also determined by using the same method ([@b0245]).

The drug release profiles were fitted into different models to determine the kinetics and mechanism of drug release. The best fit model was determined on the basis of value of coefficient of linear correlation (*R*^2^) ([@b0025]).

2.14. In vitro antifungal activity {#s0090}
----------------------------------

Agar diffusion method was used for in vitro antifungal activity testing. Freeze dried samples of *C. albicans* (MTCC 227), were revived on Malt Extract Glucose Yeast Extract Peptone Broth media (MGYPB) and stored at 4 °C. The yeast was sub-cultured in Sabouraud Dextrose Agar (SDA) media, 48 h prior to antifungal activity testing. Stock inoculum suspension was prepared in sterile saline from the subculture and was adjusted to 0.5 McFarland turbidity standards to get an approximate concentration of 1 × 10^8^ CFU mL^−1^. The prepared SDA plates were inoculated with 0.1 mL of *C. albicans* suspension and spread uniformly with the help of a sterile spreader. Blank and drug loaded films were placed onto inoculated media plates. Tween solubilized nystatin in SVF was used as a positive control. In this case, nystatin solution equivalent to 10,000 units of nystatin, was placed in wells bored in previously inoculated SDA plates. These plates were maintained at 4 °C for 2 h before incubating them at 37 °C for 24 h. The zone of inhibition (ZOI) was determined using zone reader ([@b0135]).

2.15. Stability studies {#s0095}
-----------------------

Accelerated stability studies were carried out using a stability chamber maintained at 40 ± 0.5 °C and 75 ± 5% RH. T14DT films were wrapped in aluminium foil and stored in a glass container for 6 months in the stability chamber. They were evaluated for mass uniformity, thickness, folding endurance, drug content uniformity and % drug release at 0, 3 and 6 month time intervals ([@b0160], [@b0165]).

3. Results and discussions {#s0100}
==========================

3.1. Preparation of TSP films {#s0105}
-----------------------------

TSP was found to display adequate film forming properties. The developed films were smooth and uniform in texture. The mass of prepared TSP films ranged from 57.18 ± 1.23 to 98.00 ± 1.28 mg, while thickness was found to be in the range of 1.52 ± 0.25 to 2.31 ± 0.09 mm. All the prepared films passed the folding endurance test.

3.2. Response Surface Methodological Optimization {#s0110}
-------------------------------------------------

A 3^2^ randomized full factorial design with centre point replicated four times, consisting of 13 runs (3 × 3 + 4 = 13) ([Table 1](#t0005){ref-type="table"}) was designed and the effect of independent variables (TSP concentration; *X*~1~ and PG (plasticizer) concentration; *X*~2~) was studied on the response variables (Y1--Y7) using Design Expert® software trial version 8.0.7.1(Stat-ease Inc., Minneapolis, MN, USA). The replicate experiments were included in the design to determine whether the effect of changing factor levels is significantly larger than the effect of experimental error on responses ([@b0205]). [Table 1](#t0005){ref-type="table"} depicts the values of different response variables obtained for different formulations. The obtained values were fitted into different models namely linear, 2FI (2 factor interaction), Quadratic and cubic using Design Expert® software and a suitable model was selected based on lack of fit *p*-value and *R*^2^ values. The different model fitting values are shown in [Table 2](#t0010){ref-type="table"}. Lack of fit values depicted in the Table is indicative of how effectively the model fits the data. It measures residual error to pure error. A significant lack of fit (*p* \< 0.05) is an undesirable property, because it suggests that the model does not fit the data well and hence should not be used for further predictions. Models chosen for responses Y1--Y7 had an insignificant lack of fit. The value of correlation coefficient (*R*^2^) is also an indication of the appropriateness of the selected model. Adjusted *R*^2^ represents the amount of variation that can be explained by the model. Predicted *R*^2^ represents the amount of variation in predicted values explained by the model. In the present study, the predicted *R*^2^ and the adjusted *R*^2^ of the selected models are within 0.20 (as shown in [Table 2](#t0010){ref-type="table"}) of each other indicating appropriateness of the selected models. A quadratic model was selected for responses Y2, Y3, Y6, Y7 and linear model was selected for responses Y1, Y4 and Y5. The statistical validity of the selected models was further established by ANOVA. The results are summarized in [Table 3](#t0015){ref-type="table"}. From the table it can be observed that for all the responses, the model terms are significant (*p* \< 0.05) and they have an insignificant lack of fit, which implies that the selected models are statistically significant and can be used for prediction of responses. The %CV and adequate precision values for responses Y1--Y7 were 2.37 and 92.413, 5.16 and 55.62, 1.80 and 35.637, 3.81 and 24.029, 1.97 and 26.794, 1.13 and 26.616, 3.79 and 15.897, respectively.

Eq. [(3)](#e0015){ref-type="disp-formula"} is a generalized equation representing the relationship between dependent variable (*Y*) and independent variable (*X*~1~ and *X*~2~) obtained for all the responses. The coefficients of the variables *X*~1~ and *X*~2~ in Eq. [(3)](#e0015){ref-type="disp-formula"} for different responses are compiled in [Table 4](#t0020){ref-type="table"}.$$Y = \beta_{0} + \beta_{1}X_{1} + \beta_{2}X_{2} + \beta_{3}X_{1}X_{2} + \beta_{4}X_{1}^{2} + \beta_{5}X_{2}^{2}$$

An increase in the polymer (TSP) concentration has a positive impact on the spreading coefficient, maximum force required for detachment, tensile strength, %EB, WVTR and swelling index. However, a decrease in the value of contact angle was observed with an increase in TSP. The swelling index, spreading coefficient, WVTR and maximum force required for detachment properties of a polymer are a function of the number of hydrophilic groups available for interaction with the mucus. An increase in the concentration of polymer increases the number of available groups, thereby increasing the magnitude of these properties. Further, an increase in polymer concentration also improves the contact with mucus which leads to a decrease in contact angle values ([@b0175], [@b0200]). An increase in plasticiser concentration increases the hydrophobic character of the films ([@b0150]) resulting in a decreased affinity between film surface and mucus membrane and therefore a trend opposite to that of increasing polymer concentration was observed ([@b0015], [@b0050]). These interactive effects of the formulation variable on the response variable can be easily visualized by 3D plots shown in [Figure 1](#f0005){ref-type="fig"}, [Figure 2](#f0010){ref-type="fig"}. For swelling index studies films containing 1% TSP eroded at the end of 6 h while others remained intact till the end of the study.

After establishment and analysis of appropriate models for individual responses, the simultaneous optimization of multiple responses was carried out using Design-Expert® software to find a combination of factor levels that simultaneously satisfy the requirements placed on each of the responses and factors. This process identifies those areas in design region where the system is likely to give desirable responses ([@b0070], [@b0240]). This was done graphically by overlaying critical response contours on a contour plot and identifying area of feasible response values in the factor space (yellow/lighter area in [Fig. 3](#f0015){ref-type="fig"}) as well as numerically by using desirability approach. For calculating desirability function, a desired goal (maximum, minimum, target or within range value) was chosen for each independent and response variable. The goals are then combined into a simultaneous objective function, desirability, '*D*' which is a geometric mean of all transformed responses, calculated according to the following formula:$$D = \left( {d_{1}^{r_{1}} + d_{1}^{r_{2}}\ldots\ldots d_{1}^{r_{n}}} \right)^{\frac{1}{\Sigma r_{1}}} = \left( {\prod\limits_{i = 1}^{n}d_{i}^{r_{1}}} \right)^{\frac{1}{\Sigma r_{1}}}$$where (*d~i~*) is the desirable range for each response, (*r~i~*) is the importance attached to various responses and (*n*) is the number of responses. Desirability is an objective function that ranges from zero (least desirable) to one (most desirable). Desirability is only a mathematical method to find the optimum, therefore, the goal of this optimization was to find a point that maximizes the desirability function, and meet goals set for all responses, and not just to obtain a high value. In the present research, after goal setting of all the responses, the maximum value of desirability was found to be 0.400. The optimization step gave 6 check point formulations in the desirable range and predicted 2% TSP and 15.3% v/v PG as the most desirable formulation. The other desirable formulations compositions in decreasing order of desirability were 2% TSP: 15.3% v/v PG \> 2% TSP: 15.5% v/v PG \> 2% TSP: 15.8% v/v PG \> 2% TSP: 16.5% v/v PG \> 2% TSP: 15.2% v/v PG.

3.3. Experimental verification {#s0115}
------------------------------

The check point formulations and their predicted responses were verified experimentally. All the formulations were prepared and the values of response variables were found out experimentally. The model predicted values were then compared with actual values obtained after experimentation and the percentage error in prognosis was calculated. The error was found to vary between −1.8352% and 1.8017%. Linear correlation plot between the actual and the predicted response variables is shown in [Fig. 4](#f0020){ref-type="fig"}. The plot demonstrated a high values of *R*^2^ (ranging 0.9095--0.9975) indicating excellent goodness of fit (*p* \< 0.001). Thus, the low magnitude of percentage error, as well as the significant values of *R*^2^ in the present investigation, proved the high predictability of the RSM. Further, a two tailed t-test was also applied to the predicted and actual values of all the responses and it was found that the difference in the two values was statistically insignificant, which further confirms the predictability of the designed model. Based on the above findings formulation containing 2% TSP and 15.3% v/v PG (film code T14) was selected for drug loading and further studies. The film was loaded with nystatin (film code T14D) alone or in combination with Tween 60. Tween 60 was incorporated into the films to aid solubilization of nystatin in the ratio of 1:0.5 (film code T14DT~0.5~) and 1:1 (film code T14DT) nystatin to Tween ratio.

3.4. Physiochemical interaction studies {#s0120}
---------------------------------------

[Fig. 5](#f0025){ref-type="fig"} shows the DSC profiles of T14, T14D, T14DT~0.5~, T14DT and nystatin. The thermal behaviour of the films can provide an insight into the drug--polymer compatibility, miscibility and any alteration in the chemical structure of either polymer or drug. DSC of pure nystatin revealed an endotherm which peaks at 173 °C with corresponding Δ*H* value of 238 J g^−1^. DSC of T14 film shows an initial endotherm followed by an exotherm with peaks at 120 °C and 309 °C, respectively. When nystatin was incorporated into the film (T14D) an additional sharp peak corresponding to the melting peak of nystatin is observed at 172 °C (Δ*H* = 155 J g^−1^) indicating the presence of crystalline un-solubilized drug. This peak however, reduced in intensity and enthalpy (Δ*H* = 64 J g^−1^) with the addition of small quantity of Tween (T14DT~0.5~) and completely disappeared when the quantity of Tween was increased (T14DT). The decline in enthalpy and intensity indicates only partial solubilization of nystatin in the film indicating that 1:0.5 ratio of drug to Tween is not sufficient to cause complete solubilization of the incorporated drug. The absence of nystatin melting peak in T14DT indicates transformation of crystalline drug into amorphous state as a consequence of solubilization effect of Tween. Tween 60 was able to cause micellar solubilization of nystatin. This conclusion can be further supported by the fact that the concentration of Tween 60 used in T14DT was greater than its critical micellar concentration value (30 μg mL^−1^) thus, ensuring formation of micelles and nystatin solubilization ([@b0230]).

SEM analysis of the film ([Fig. 6](#f0030){ref-type="fig"}) also confirmed the above findings. Blank TSP films (T14) ([Fig. 6](#f0030){ref-type="fig"}a) showed smooth texture indicating uniformity of polymer matrix. The un-solubilized drug particles were clearly evident in T14D films ([Fig. 6](#f0030){ref-type="fig"}b). Addition of Tween in T14DT~0.5~ ([Fig. 6](#f0030){ref-type="fig"}c) partially solubilized nystatin and also created some smoothness in the film texture, while a completely smooth texture with no visible drug particles was observed for T14DT films ([Fig. 6](#f0030){ref-type="fig"}d). Based on the above findings that T14DT films were used for drug release studies.

3.5. Drug content uniformity, in vitro drug release and residence time {#s0125}
----------------------------------------------------------------------

The drug content of T14DT was found to be 98.23 ± 0.67% suggesting that the film casting process led to the development of films with uniform drug dispersion.

The in vitro drug release studies were carried out on T14DT films loaded with nystatin solubilized with Tween. Samples were collected at fixed intervals, and the amount of nystatin released from the formulation with respect to time was calculated. The bioadhesive film formulation was releasing 73.92 ± 2.54% of nystatin ([Fig. 7](#f0035){ref-type="fig"}) at the end of 8 h. Release data from the films was subjected to model fitting equations namely, zero order, first order, Higuchi, Weibull and Korsmeyer--Peppas model in order to determine the rate of drug release. The release data showed best fit to Korsmeyer--Peppas model with *R*^2^ of 0.9996. The value of release exponent *n* was calculated to be 1.19, suggesting the release mechanism to be super case-II.

Residence time of the formulation was found to be about 510 ± 5 min.

3.6. In vitro antifungal activity {#s0130}
---------------------------------

Tamarind has been shown to possess antifungal activity against *C. albicans*. This activity has been ascribed to the presence of some essential oils or secondary metabolites. However, several other studies have completely ruled out any such activity ([@b0040], [@b0045], [@b0065]). In order to explore this fact and to see whether TSP can exert any synergistic anti candida activity along with the nystatin incorporated in the film, blank TSP films were subjected to antifungal activity testing. Films with different TSP concentrations (1%, 1.5%, 2% w/v TSP) namely T1, T4 and T7 were placed on the inoculated SDA plates and were observed for appearance of ZOI at the end of the study. No ZOI was observed for the blank TSP films. Absence of ZOI in blank TSP films may be correlated with loss of essential oil/secondary metabolites (which are proposed to have antifungal activity in the literature) during the extraction process of TSP. Thus, synergistic antifungal effect from the polymer can be ruled out in drug loaded TSP films in the present study.

For antifungal activity of drug loaded films, T14DT films were placed on the inoculated SDA plates and were observed for appearance of ZOI against T14 films and nystatin solution acting as the negative and positive control groups respectively. A ZOI of 1.1 ± 0.2 cm was observed for T14DT films. ZOI for nystatin solution was 1.5 ± 0.1 cm, while no ZOI was observed for T14 films. These results indicate antifungal characteristics of the prepared film.

3.7. Stability studies {#s0135}
----------------------

For assessment of film stability three time points (0, 3, 6 months) were used. T14DT was assessed for mass uniformity, thickness, folding endurance, drug content and % drug release at each time point. The results are shown in [Table 5](#t0025){ref-type="table"}. No significant difference (*p* \< 0.05) was observed in these properties indicating that the films remained stable throughout the study period.

4. Conclusion {#s0140}
=============

Bioadhesive vaginal films containing tamarind seed polysaccharide were successfully prepared and characterized for their bioadhesive, mechanical, swelling and interfacial properties and optimized using response surface methodology. The results of RSM optimization indicated that the formulation containing 2% TSP and 15.3% v/v PG possessed most desirable properties. The optimized formulation was loaded with micellar solubilized nystatin. These were able to release 73.92 ± 2.54% of nystatin and also exhibited appropriate residence time in vitro. The drug release followed Korsmeyer--Peppas kinetics with *R*^2^ of 0.9990. The optimized film also showed appropriate anti candida activity through appearance of zone of inhibition during antifungal activity testing study. Thus, the developed TSP films can be proposed as a befitting candidate for vaginal delivery of drugs.
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![Physicochemical interactions between blank (T14) and drug loaded TSP films with nystatin and Tween in ratio of 1:0 (T14D), 1:0.5 (T14DT~0.5~) and 1:1 (T14DT).](gr5){#f0025}

![Surface morphology of blank (a), drug loaded TSP films with nystatin and Tween in ratio of 1:0 (b), 1:0.5 (c), and 1:1 (d).](gr6){#f0030}
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###### 

A 3^2^ full factorial design with replicated centre point and the values obtained for different response variables.

  Batch no.   Independent variables   Response/dependent variables                                                                 
  ----------- ----------------------- ------------------------------ ----- ------ ------- -------- -------- ------ ------- ------- --------
  T1          −1                      −1                             1.0   15.0   30.00   −9.27    75.00    6.41   8.91    13.80   119.21
  T2          −1                      0                              1.0   17.5   34.00   −11.83   76.00    6.38   9.37    12.50   105.38
  T3          −1                      1                              1.0   20.0   37.00   −13.93   72.00    6.34   9.88    12.10   102.76
  T4          0                       −1                             1.5   15.0   21.00   −4.60    79.00    7.92   9.39    14.30   128.22
  T5          0                       0                              1.5   17.5   24.00   −5.98    77.00    7.98   10.30   13.70   110.16
  T6          0                       1                              1.5   20.0   27.00   −7.54    73.00    7.86   10.47   13.50   106.36
  T7          1                       −1                             2.0   15.0   12.00   −1.51    106.00   9.77   10.71   14.90   147.86
  T8          1                       0                              2.0   17.5   14.00   −2.06    104.00   9.82   10.78   14.50   138.65
  T9          1                       1                              2.0   20.0   18.00   −3.39    92.00    9.95   11.56   14.10   121.73
  T10         0                       0                              1.5   17.5   24.00   −5.98    76.00    7.89   10.51   13.70   108.26
  T11         0                       0                              1.5   17.5   24.00   −5.98    77.00    7.11   10.33   13.50   113.13
  T12         0                       0                              1.5   17.5   25.00   −6.22    77.00    7.82   10.24   13.70   121.49
  T13         0                       0                              1.5   17.5   23.00   −5.21    75.00    7.89   10.41   13.60   115.30

TSP: tamarind seed polysaccharide.

PG: propylene glycol.

EB: elongation at break.

WVTR: water vapour transmission rate.

Swelling index values at the end of 6 h.

###### 

Lack of fit *p*-value and *R*^2^ values for model selection of different response variables.

                                 Sequential *p*-value   *R*^2^   Adjusted *R*^2^   Predicted *R*^2^   Lack of fit *p*-value   Comments
  ------------------------------ ---------------------- -------- ----------------- ------------------ ----------------------- -----------
  *Contact angle (Y1)*                                                                                                        
  Linear                         \<0.0001               0.9946   0.9935            0.9913             0.8367                  Suggested
  2FI                            0.4094                 0.9950   0.9934            0.9887             0.8273                  
  Quadratic                      0.8567                 0.9952   0.9918            0.9807             0.6564                  
  Cubic                          0.4252                 0.9966   0.9919            0.9869             0.7837                  Aliased
                                                                                                                              
  *Spreading coefficient (Y2)*                                                                                                
  Linear                         \<0.0001               0.9578   0.9494            0.9088             0.0450                  
  2FI                            0.0812                 0.9705   0.9606            0.8882             0.0662                  
  Quadratic                      0.0020                 0.9950   0.9914            0.9829             0.7676                  Suggested
  Cubic                          0.5475                 0.9960   0.9905            0.9873             0.8150                  Aliased
                                                                                                                              
  *Max detachment force (Y3)*                                                                                                 
  Linear                         0.0021                 0.7091   0.6509            0.4515             0.0003                  
  2FI                            0.4480                 0.7281   0.6375            0.1675             0.0002                  
  Quadratic                      \<0.0001               0.9905   0.9837            0.9373             0.0779                  Suggested
  Cubic                          0.4463                 0.9931   0.9835            0.4319             0.0359                  Aliased
                                                                                                                              
  *Tensile strength (Y4)*                                                                                                     
  Linear                         \<0.0001               0.9519   0.9423            0.9280             0.7645                  Suggested
  2FI                            0.7013                 0.9527   0.9370            0.8887             0.6977                  
  Quadratic                      0.1520                 0.9724   0.9527            0.9539             0.9849                  
  Cubic                          0.9759                 0.9727   0.9344            0.8847             0.7692                  Aliased
                                                                                                                              
  *%EB (Y5)*                                                                                                                  
  Linear                         \<0.0001               0.9298   0.9157            0.8858             0.0601                  Suggested
  2FI                            0.7833                 0.9304   0.9072            0.8642             0.0463                  
  Quadratic                      0.6282                 0.9390   0.8955            0.5984             0.0277                  
  Cubic                          0.7059                 0.9470   0.8727            −4.2936            0.0080                  Aliased
                                                                                                                              
  *WVTR (Y6)*                                                                                                                 
  Linear                         \<0.0001               0.9183   0.9020            0.8181             0.0190                  
  2FI                            0.0470                 0.9486   0.9314            0.8605             0.0343                  
  Quadratic                      0.0808                 0.9749   0.9570            0.7869             0.0637                  Suggested
  Cubic                          0.0169                 0.9951   0.9882            0.9784             0.7615                  Aliased
                                                                                                                              
  *Swelling index (Y7)*                                                                                                       
  Linear                         0.0002                 0.8242   0.7890            0.6894             0.3097                  
  2FI                            0.4618                 0.8350   0.7800            0.4729             0.2768                  
  Quadratic                      0.0386                 0.9349   0.8884            0.7713             0.7350                  Suggested
  Cubic                          0.5502                 0.9487   0.8769            0.6491             0.6801                  Aliased

###### 

ANOVA results for the selected models for different responses.

  Response      Source            Sum of squares   DF[a](#tblfn6){ref-type="table-fn"}   Mean square   *F* value   *p*-Value Prob \> *F*   Comments
  ------------- ----------------- ---------------- ------------------------------------- ------------- ----------- ----------------------- -------------
  Y1            Quadratic model   2004.0362        5                                     400.8072      433.1556    \<0.0001                Significant
  Lack of fit   4.8320            3                1.6107                                3.9158        0.1102      Not significant         
                                                                                                                                           
  Y2            Linear model      0.7029           2                                     0.3514        83.2927     \<0.0001                Significant
  Lack of fit   0.0121            6                0.0020                                0.2685        0.9257      Not significant         
                                                                                                                                           
  Y3            Linear model      601.6667         2                                     300.8333      923.8189    \<0.0001                Significant
  Lack of fit   1.2564            6                0.2094                                0.4188        0.8367      Not significant         
                                                                                                                                           
  Y4            Quadratic model   151.97284        5                                     30.3946       277.0218    \<0.0001                Significant
  Lack of fit   0.1737            3                0.0579                                0.3897        0.7676      Not Significant         
                                                                                                                                           
  Y5            Quadratic model   1576.1244        5                                     315.2249      146.0696    \<0.0001                Significant
  Lack of fit   11.9063           3                3.9688                                4.9610        0.0779      Not significant         
                                                                                                                                           
  Y6            Linear model      18.0618          2                                     9.0309        98.9858     \<0.0001                Significant
  Lack of fit   0.4065            6                0.0677                                0.5356        0.7645      Not significant         
                                                                                                                                           
  Y7            Linear model      5.3870           2                                     2.6935        66.1823     \<0.0001                Significant
  Lack of fit   0.3631            6                0.0605                                5.5166        0.0601      Not significant         
                                                                                                                                           
  Y8            Quadratic model   6.5291           5                                     1.3058        54.4593     \<0.0001                Significant
  Lack of fit   0.1358            3                0.0453                                5.6602        0.0637      Not significant         
                                                                                                                                           
  Y9            Quadratic model   2022.0026        5                                     404.4005      20.1006     0.0005                  Significant
  Lack of fit   35.1430           3                11.7143                               0.4434        0.7350      Not significant         

DF: degree of freedom.

###### 

Values of coefficients obtained for variables *X*~1~ and *X*~2~ in the equations generated for different response variables.[a](#tblfn7){ref-type="table-fn"}

  Coefficient value   Contact angle   Spreading coefficient   Maximum detachment force   Tensile strength   %EB     WVTR    Swelling index
  ------------------- --------------- ----------------------- -------------------------- ------------------ ------- ------- ----------------
  *β*~0~              24.08           −5.89                   76.86                      7.93               10.22   13.64   114.05
  *β*~1~              −9.50           4.68                    13.17                      1.74               0.82    0.85    13.48
  *β*~2~              3.17            −1.58                   −3.83                      8.33E−003          0.48    −0.55   −10.74
  *β*~3~              0.00            0.70                    −2.75                      0.00               0.00    0.23    −2.42
  *β*~4~              0.00            −1.02                   11.98                      0.00               0.00    −0.16   7.02
  *β*~5~              0.00            −0.14                   −2.02                      0.00               0.00    0.24    2.30

The *β*~3~, *β*~4~, *β*~5~ coefficient values of contact angle, tensile strength and %EB are zero since they were found to have a linear fit.

###### 

Stabiliy studies for T14DT films.

  Parameter           0 Month        3 Months       6 Months
  ------------------- -------------- -------------- ---------------
  Mass (mg)           103.4 ± 1.04   103.4 ± 0.70   102.73 ± 0.56
  Thickness (mm)      2.04 ± 0.03    2.03 ± 0.02    2.03 ± 0.02
  Folding endurance   \>300          \>300          \>300
  \% Drug content     98.23 ± 0.67   98.29 ± 0.64   98.21 ± 0.68
  \% Drug release     73.92 ± 2.54   73.49 ± 0.99   73.24 ± 0.74
